Literature DB >> 20619937

Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.

Sadim Jawhar1, Anna Trawicka, Carolin Jenneckens, Thomas A Bayer, Oliver Wirths.   

Abstract

In the present report, we extend previous findings in the 5XFAD mouse model and demonstrate that these mice develop an age-dependent motor phenotype in addition to working memory deficits and reduced anxiety levels as demonstrated in an elevated plus maze task. Employing a variety of N- and C-terminal specific Aβ antibodies, abundant intraneuronal and plaque-associated pathology, including accumulation of pyroglutamate Aβ, was observed as early as the age of 3 months. Using unbiased stereology, we demonstrate that the 5XFAD mice develop a significant selective neuron loss in layer 5 of the cortex, leaving the overall neuron number of the total frontal cortex and hippocampus unaffected. This observation coincides with the accumulation of intraneuronal Aβ peptides only in cortical Layer 5, but not in CA1, despite comparable APP expression levels. The motor phenotype correlates with abundant spinal cord pathology, as demonstrated by abundant intraneuronal Aβ accumulation and extracellular plaque deposition. In addition, comparable to the APP/PS1KI mouse model, 5XFAD mice develop an age-dependent axonopathy likely contributing to the behavioral deficits.
Copyright © 2012 IBRO. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619937     DOI: 10.1016/j.neurobiolaging.2010.05.027

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  179 in total

1.  5XFAD mice show early-onset gap encoding deficits in the auditory cortex.

Authors:  Aldis P Weible; Amanda J Stebritz; Michael Wehr
Journal:  Neurobiol Aging       Date:  2020-06-01       Impact factor: 4.673

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

3.  Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.

Authors:  Pooneh Memar Ardestani; Andrew K Evans; Bitna Yi; Tiffany Nguyen; Laurence Coutellier; Mehrdad Shamloo
Journal:  Neuropharmacology       Date:  2017-01-13       Impact factor: 5.250

4.  Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.

Authors:  L Devi; M Ohno
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

5.  Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.

Authors:  T J Flanigan; Y Xue; S Kishan Rao; A Dhanushkodi; M P McDonald
Journal:  Genes Brain Behav       Date:  2014-04-22       Impact factor: 3.449

6.  Visible spectrum extended-focus optical coherence microscopy for label-free sub-cellular tomography.

Authors:  Paul J Marchand; Arno Bouwens; Daniel Szlag; David Nguyen; Adrien Descloux; Miguel Sison; Séverine Coquoz; Jérôme Extermann; Theo Lasser
Journal:  Biomed Opt Express       Date:  2017-06-20       Impact factor: 3.732

7.  In utero exposure to fine particulate matter results in an altered neuroimmune phenotype in adult mice.

Authors:  Joshua A Kulas; Jordan V Hettwer; Mona Sohrabi; Justine E Melvin; Gunjan D Manocha; Kendra L Puig; Matthew W Gorr; Vineeta Tanwar; Michael P McDonald; Loren E Wold; Colin K Combs
Journal:  Environ Pollut       Date:  2018-05-22       Impact factor: 8.071

8.  Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.

Authors:  Melanie Hüttenrauch; Susanne Walter; Margie Kaufmann; Sascha Weggen; Oliver Wirths
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

9.  Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Neuron loss in transgenic mouse models of Alzheimer's disease.

Authors:  Oliver Wirths; Thomas A Bayer
Journal:  Int J Alzheimers Dis       Date:  2010-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.